40 /100
MEDIUM RISK
Score updated May 30, 2026

COEP — Coeptis Therapeutics Holdings Inc Dilution Risk Tracker

Track COEP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track COEP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
25%
📉 Score Deterioration 40%
• Score rose 20 points recently (worsening)
💰 Capital Raise 18%
• Active ATM program with $20M remaining capacity
🔔 Track COEP — Get forecast alerts →

💹 Market Data

Market Cap$102.06M
Shares Outstanding6.22M
Float5.25M
Cash$6.35M
Debt$268.9K
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest429.8K
Days to Cover9.8
% of Float8.2%
FINRA data as of Apr 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
8-K 8K EVENT May 01, 2026
4 INSIDER TRANSACTION Apr 30, 2026
4 INSIDER TRANSACTION Apr 30, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track COEP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking COEP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for COEP
📊 COEP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 COEP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.